This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.
|
OHSU Doernbecher is first hospital in Pacific Northwest to offer new FDA-approved treatment for advanced leukemiaThe first FDA-approved gene transfer therapy for patients with acute lymphoblastic leukemia will be available at a handful of approved hospitals, including OHSU Doernbecher.
|
|
This email was sent to you by Oregon Health & Science University 3181 S.W. Sam Jackson Park Rd. | Portland, Oregon 97239-3098 |